lundi 12 octobre 2015

Onco Actu du 12 octobre 2015

1. Biologie

Genomic features of lobular breast carcinoma [National Cancer Institute]

Why elephants hardly ever get cancer and how that can help us [NHS Choices]

The Elephant (not) in the Cancer Ward [The Mermaid's Tale]

3. Prévention

New NIH breast cancer research to focus on prevention [NIH]

4.5 Dép., diag. & prono. - Colorectal

Myriad to Present New Data on Its myRisk(TM) Hereditary Cancer Test at the CGA-ICC Annual Meeting [Myria]

4.7 Dép., diag. & prono. - Col de l'utérus

Roche Wins the first HPV Primary Screening Tender in Europe [Roche]

4.9 Dép., diag. & prono. - Sein

Yes, Early Breast Cancer Detection Does Matter, New Study Finds [Forbes]

5.2 Pharma

Lilly upgrades its NYC research hub, adding 50 jobs in an immuno-oncology push [FierceBiotech]

AstraZeneca halts a pair of lung cancer trials over a safety scare [FierceBiotech]

AstraZeneca pauses two lung cancer drug combination trials [Reuters]

5.2.1 Pharma - Partenariats

Boehringer Ingelheim and Philogen collaborate to investigate novel treatment approaches for Acute Myeloid Leukemia [Boehringer Ingelheim]

Lilly and Innovent Biologics Expand Their Strategic Alliance to Include Immuno-Oncology Bispecific Antibodies in China and Globally [Lilly]

5.3.4 Traitements - AMM (FDA, EMA)

Bristol-Myers Squibb’s Opdivo (nivolumab) Receives Expanded FDA Approval in Previously-Treated Metastatic Non-Small Cell Lung Cancer (NSCLC), Offering Improved Survival to More Patients [BMS]

FDA expands approved use of Opdivo in advanced lung cancer [FDA]

FDA expands lung cancer approval for Bristol-Myers' drug [Reuters]

5.4 Traitements - Economie

U.K. cost watchdog gives second thumbs-up in a week to Merck's Keytruda for skin cancer [FiercePharma]

NICE recommends pembrolizumab for advanced skin cancer not treated with ipilimumab [NICE]

6.1 Observation

MSK Study Examines Cancer-Care Outcomes among US Hospitals [MSKCC]

6.3 Associations

The 7 questions we must answer to beat cancer [Cancer Research UK]

Cancer Research UK launches £100m grand challenges to tackle the most important questions in cancer [Cancer Research UK]

Cancer Research UK announces grand challenges competition [Science]

Charity offers £100m for new ways to beat cancer [BBC News]

6.4 Médico-éco

Study: US spends more on health with worse results [The Hill]

6.5 Médecines alternatives

Ben Carson’s alternative cancer cure testimonial for Mannatech [Respectful Insolence]

6.7 DMP, Big Data & applis

Cancer drug development time halved thanks to artificial intelligence [The Telegraph]

6.9 Controverses

Standing up for science [Nature Biotechnology]